Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Marazioti, A. Moustaki, M. Spella, A. Giannou, M. Iliopoulou, D. Kardamakis, G. Stathopoulos (Patras, Greece). A requirement for kras signaling in malignant pleural effusion. Eur Respir J 2013; 42: Suppl. 57, 1513

Member's Comments

No comment yet.

Related content which might interest you: A myeloid NF-κbeta response in malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 A conditional contribution of mast cells to malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Outpatient management of malignant pleural effusion in patients unfit for pleurodesis Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Efficacy of cytology, cell blocks and thoracoscopic pleural biopsy in malignant pleural effusion diagnosis Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Solitary fibrous tumour of the pleural: Two malignant cases Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Role of tumor derived versican in experimental malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE) Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 LATE-BREAKING ABSTRACT: Host-environmental IL-1ß drives mutant KRAS-IKKa addiction in malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Pleural mesothelioma: Our experience in 132 cases Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 A novel pleural-bladder pump for management of pleural effusion Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Medical pleuroscoy, role in undiagnosed pleural effusion and therapy for pneumothorax and recurrent pleural effusion Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Pericardiodesis in pericardial tamponade Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant pleural effusion as the initial manifestation of gynecological malignancies Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Haematologic parameters and their prognostic impact in malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant pleural mesothelioma: Current status and future projections in Turkey Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015